Home > Browse Reports > Biotechnology > Veterinary Health Markets

Report Description

Veterinary Health Markets
Publication Date: 01-DEC-08
Pages: 303
Study: TMRVET
Format/Price: PDF document / $3,400.00
   


Description:



View Sample PDF


Profound changes are happening in the animal health market. Pet owners in the United States are demanding more advanced and expensive treatments for companion animals, driving growth in the companion-animal sector. At the same time, concerns about livestock health care and feeding are driving changes in industrial animal husbandry. This TriMark Publications report offers a broad, yet detailed, overview of the shape of the veterinary health products market over the next several years. Examining both livestock and companion-animal markets. The overall market for veterinary therapeutics and diagnostic products has grown dramatically. This report analyzes the U.S. veterinary pharmaceuticals and diagnostics markets. The report outlines market size, market growth, forecasts, and competitive information. Focusing both on companion (pet) animal markets and agricultural livestock, the report examines the markets for pharmaceuticals, vaccines, diagnostics, and feed additives. The study reveals: the size of the markets for companion-animal products, broken down by type of animal (i.e., cats, dogs, small animals, etc.); size of the markets for livestock products; how the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) regulations impact these markets; the identity of the top market players, along with their market shares and future prospects; how the antibiotic feed additive controversy is influencing the agricultural market; and key players in the veterinary pharma and diagnostic markets.





Table of Contents:

  1. 1. Overview 7
  2. 1.1 Objective of Report 7
  3. 1.2 Scope of Report 7
  4. 1.3 Methodology 8
  5. 1.4 Executive Summary 9
  6. 2. Veterinary Biological Products 11
  7. 2.1 Overview of Health Products Market 11
  8. 2.1.1 World Products Markets 11
  9. 2.1.2 U.S. Animal Health Products Market 14
  10. 2.1.3 European Animal Health Markets 15
  11. 2.1.4 Asian Animal Health Products Markets 16
  12. 2.1.5 Rest of World 23
  13. 2.1.6 World Market Share 23
  14. 2.1.7 Common Animal Diseases 24
  15. 2.1.8 Companion Animals 54
  16. 2.2 Veterinary Vaccines 57
  17. 2.2.1 Major Canine Vaccines 59
  18. 2.2.2 Major Feline Vaccines 61
  19. 2.3 Agricultural Animals 67
  20. 2.3.1 Major Cattle Vaccines 69
  21. 2.3.2 Major Poultry Vaccines 74
  22. 2.3.3 Major Sheep Vaccines 81
  23. 2.3.4 Major Swine Vaccines 84
  24. 2.3.5 Horses 89
  25. 2.4 Trends in the Biologicals Market 92
  26. 2.5 Nutraceuticals 94
  27. 2.5.1 Nutraceutical Market for Companion Animals 94
  28. 2.6 OTC Animal Health Global Market Opportunity 98
  29. 3. Veterinary Pharmaceutical Products 99
  30. 3.1 Overview 99
  31. 3.1.1 Pharmaceutical Products for Dogs and Cats 104
  32. 3.1.1.1 Antiparasitics 108
  33. 3.1.1.2 Antibiotics 110
  34. 3.1.1.3 Anti-Inflammatories 114
  35. 3.1.1.4 Chronic Care Products 117
  36. 3.1.1.5 Cardiovasculars 117
  37. 3.1.1.6 GI Products 118
  38. 3.1.1.7 Endocrine Products 118
  39. 3.1.1.8 Anti-Infectives 119
  40. 3.1.1.9 Behavior Modifiers 120
  41. 3.1.1.10 Anthelminitics 120
  42. 3.1.1.11 Antifungals 121
  43. 3.1.1.12 Cancer and Chemotherapy in Companion Animals 121
  44. 3.1.2 Pharmaceutical Products for Agricultural Animals 131
  45. 3.1.2.1 Antiparasites 131
  46. 3.1.2.2 Antibiotics 132
  47. 3.1.2.3 Insecticides 133
  48. 3.2 Leading Products and Competitors 134
  49. 3.2.1 Elanco 134
  50. 3.2.2 Novartis 135
  51. 3.2.3 Alpharma 136
  52. 3.2.4 Wyeth 138
  53. 3.2.5 Pfizer Animal Health 138
  54. 3.3 Veterinary Pharmaceutical Market Trends 139
  55. 3.4 Companion-Animal Crossover Products 140
  56. 3.5 Generics in the Animal Health Sector 141
  57. 4. Veterinary Feed Additive Products 142
  58. 4.1 Overview 142
  59. 4.2 U.S. Feed Additives Market 147
  60. 4.3 Leading Feed Additives and Competitors 147
  61. 4.4 Feed Additives Market Trends 149
  62. 4.4.1 Livestock Performance Enhancers 150
  63. 4.5 Pet Food Additives and Contaminants 152
  64. 4.5.1 Pet Deaths 153
  65. 4.5.2 The FDA Response 153
  66. 5. Veterinary Diagnostic Test Products 154
  67. 5.1 Introduction 154
  68. 5.2 Veterinary Diagnostic Market Size and Growth Rates 156
  69. 5.2.1 Market Drivers 159
  70. 5.2.2 Immunodiagnostic and Nucleic Acid Testing Markets 159
  71. 5.2.2.1 Market Size and Growth 159
  72. 5.2.3 Technological Developments in the Diagnostic Industry 159
  73. 5.3 Competitive Situation 161
  74. 5.4 Estimate of Units Sold and Pricing 162
  75. 5.5 PCR Applications for Veterinary Use 162
  76. 5.6 Companion-Animal Diagnostics 166
  77. 5.6.1 Feline Leukemia Virus 166
  78. 5.7 Agricultural Animal Diagnostics 167
  79. 5.8 U.S. Diagnostic Test Market 168
  80. 5.9 Leading Competitors in Diagnostic Testing 169
  81. 5.10 Veterinary Diagnostic Market Trends 172
  82. 5.11 Collaborative Licensing 173
  83. 5.12 BSE Diagnostic Tests 173
  84. 5.13 West Nile Virus Diagnostic Tests 174
  85. 5.14 Avian Flu Diagnostic Tests 174
  86. 6. Overview of the Veterinary Health Market 175
  87. 6.1 Regulatory Environment 175
  88. 6.1.1 International Bodies for Regulation of Animal Health Products 176
  89. 6.1.1.1 Regulation of Animal Health Products in the E.U. 178
  90. 6.1.1.2 Regulation of Animal Health Products in the U.S. 180
  91. 6.1.1.3 Regulation of Animal Health Products in Japan 181
  92. 6.1.2 Proposed Regulation of Animal Antibiotics 182
  93. 6.2 The European Animal Health Industry 183
  94. 6.2.1 Trends Driving Demand 183
  95. 6.2.1.1 European, International and U.S. Oversight of Veterinary Medicines 183
  96. 6.2.1.2 Antibiotic Usage 184
  97. 6.3 Mergers and Acquisitions 184
  98. 6.4 New Product Launches 186
  99. 6.5 Bioterrorism and Foodborne PathogensWHO Guidelines 187
  100. 6.5.1 The U.S. Bioterrorism Preparedness and Response Act, 2002 188
  101. 6.6 Generic Products 188
  102. 7. Emerging Markets 191
  103. 7.1 Biotechnology and Veterinary Health 191
  104. 7.1.1 Biotechnology and Biologics 191
  105. 7.1.1.1 Recombinant DNA Vaccines 191
  106. 7.1.1.2 Plant-derived Vaccines 192
  107. 7.1.2 DNA Probes 192
  108. 7.1.3 Biotechnology and Pharmaceuticals 193
  109. 7.1.3.1 Immunodiagnostic Applications 193
  110. 7.1.3.2 Growth Enhancers 194
  111. 7.2 Impact of Genomics on Veterinary Health 194
  112. 7.2.1 Autosomal Dominant Traits 197
  113. 7.2.2 X-Linked Traits 197
  114. 7.2.3 Autosomal Recessive Traits 198
  115. 7.2.4 Current DNA Testing in Animals 199
  116. 7.2.5 Direct DNA Testing: Mutation-based Tests 200
  117. 7.2.6 Indirect DNA Testing: Linkage-based or Marker-Based Tests 200
  118. 7.3 Companion-Animal Markets 200
  119. 7.4 Alternative Medicine in Veterinary Practice 201
  120. 7.5 Generics in the Animal Health Market 201
  121. 7.6 Pet Insurance 207
  122. 7.7 Orthotics and Prosthetics for Animals 209
  123. 7.8 Pet Cloning 211
  124. 8. Company Profiles 212
  125. 8.1 Abaxis, Inc. 212
  126. 8.2 Abbott Laboratories 214
  127. 8.3 Adiagene 215
  128. 8.4 Agricultural Research Service 215
  129. 8.5 Alpharma, Inc. 216
  130. 8.6 Avian Biotech 218
  131. 8.7 BASF 218
  132. 8.8 Bayer Animal Health 219
  133. 8.9 Biobest Laboratories 220
  134. 8.10 BioVet, Inc. 221
  135. 8.11 Boehringer Ingelheim Corp. 222
  136. 8.12 CEVA Santé Animale 222
  137. 8.13 Cypress Diagnostics 224
  138. 8.14 Dabaco Viet Nam Corporation 225
  139. 8.15 DayMoon Industries, Inc. 225
  140. 8.16 Dow AgroSciences LLC 226
  141. 8.17 Dupont Qualicon 226
  142. 8.18 Egyptian International Pharmaceutical Industries Company 227
  143. 8.19 Elanco Animal Health 227
  144. 8.20 Eurofins Medigenomix GmbH 228
  145. 8.21 Fort Dodge Animal Health 228
  146. 8.22 Gene Check, Inc. 229
  147. 8.23 Heska 230
  148. 8.24 Huvepharma 232
  149. 8.25 IDEXX Laboratories, Inc. 232
  150. 8.26 Intervet/Schering-Plough Animal Health 235
  151. 8.27 IWAKI & Co., Ltd. 235
  152. 8.28 Janssen Pharmaceutica 236
  153. 8.29 Laboklin 237
  154. 8.30 Medika d.d. 237
  155. 8.31 Merial 237
  156. 8.32 MetaMorphix, Inc. 238
  157. 8.33 Microbix Biosystems, Inc. 240
  158. 8.34 Momina krepost AD Veliko Tarnovo 240
  159. 8.35 Monsanto 240
  160. 8.36 Mosaic Company 241
  161. 8.37 Neogen Corporation 242
  162. 8.38 Novartis Animal Health 244
  163. 8.39 OptiGen 245
  164. 8.40 Orion Corporation 246
  165. 8.41 PETCO Animal Supplies, Inc. 247
  166. 8.42 PetSmart, Inc. 248
  167. 8.43 Pfizer Animal Health 249
  168. 8.44 Phylaxia Pharma NyRt. 255
  169. 8.45 Sanofi-Aventis 255
  170. 8.46 Schering-Plough Animal Health Corporation 256
  171. 8.47 Skystar Bio-Pharmaceutical Company 257
  172. 8.48 Sunwin International Nutraceuticals 257
  173. 8.49 Synbiotics Corporation 257
  174. 8.50 Teva Pharmaceutical Industries Ltd. 258
  175. 8.51 The Arab Pesticides and Veterinary Drugs Mfg. Co. 259
  176. 8.52 ThermoGenesis Corp. 260
  177. 8.53 VCA Antech, Inc. 260
  178. 8.54 Velefarm ad Beograd 262
  179. 8.55 Veterinarski Zavod Subotica ad Subotica 262
  180. 8.56 Vétoquinol 262
  181. 8.57 Virbac SA 262
  182. 8.58 WooGene B&G Co., Ltd 263
  183. 8.59 Wyeth 263
  184. 9. Business Trends in the Industry 265
  185. 9.1 Animal Health Additive Growth Trends 265
  186. 9.2 Move to Complete Product Portfolio 265
  187. 9.3 Reduced Antibiotic Usage in Animal Feeds 265
  188. 9.4 European Animal Health Industry 265
  189. 9.5 Licensing and Partnership Opportunities in Animal Health R&D 266
  190. 10. Company Directory 267
  191. Appendix 1: Dosages for Selected Drugs Alphabetical Listing 276
  192. Appendix 2: Trade Names 289
  193. Appendix 3: Abbreviations 301
  194. INDEX OF FIGURES
  195. Figure 2.1: Global Animal Health Market by Product Category, 2007 11
  196. Figure 2.2: Worldwide Sales of Animal Health Products by Product Class, 2007 12
  197. Figure 2.3: Worldwide Animal Health Industry Revenues by Species, 2007 13
  198. Figure 2.4: Worldwide Animal Health Products Market by Region, 2007 13
  199. Figure 2.5: Market Share for the Top Ten Animal Health Companies, 2007 14
  200. Figure 2.6: U.S. Companion Animal Healthcare Products Share of Overall Animal Health Product Sales, 2007 15
  201. Figure 2.7: Pet Population in Japan, 1996 and 2006 17
  202. Figure 2.8: Swine Population in Japan, 2006-2008 18
  203. Figure 2.9: Cattle Population in Japan, 2006-2008 19
  204. Figure 2.10: The Indian Biologicals Industry by Product Category, 2007 21
  205. Figure 2.11: South African Animal Health Market by Product Category, 2007 23
  206. Figure 2.12: Global Incidence of Avian H5N1, 2008 76
  207. Figure 2.13: Global incidence of Equine Herpesvirus Type 1, 2008 89
  208. Figure 2.14: Global Outbreaks of Equine Viral Arteritis, 2008 92
  209. Figure 3.1: Animal Health Product Sales in the U.S., 2005-2014 103
  210. Figure 3.2: Expenditure on Pets in Australia by Pet Type, 2005 108
  211. Figure 3.3: Pet care Expenditure in Australia by Category, 2005 108
  212. Figure 3.4: The European Parasiticide Market by Product Category, 2007 110
  213. Figure 3.5: Growth in Global Sales of Antibiotic Products, 2005-2012 132
  214. Figure 3.6: Novartis Animal Health Division: Business Split, 2007 135
  215. Figure 3.7: Novartis Animal Health Division: Product Split, 2007 136
  216. Figure 3.8: Novartis Animal Health Division: Sales by Geographic Region, 2007 136
  217. Figure 4.1: Global Market for Livestock Performance Enhancers, 2006 152
  218. Figure 5.1: Growth of the Lateral Flow Diagnostic Tests in the Veterinary Market, 2005-2015 160
  219. Figure 7.1: The U.S. Market for Companion Animal Pharmaceuticals, 2007 201
  220. Figure 7.2: U.S. Companion Animal Pharmaceuticals: Percentage of New Generics, 2007 204
  221. Figure 7.3: U.S. Market for FDA-approved Pharmaceuticals for Companion Animals, 2007 205
  222. LIST OF TABLES
  223. Table 2.1: World Market for Animal Health Products, 2002-2012 11
  224. Table 2.2: Global Sales of Animal Health and Nutrition Products, 2004-2012 12
  225. Table 2.3: Worldwide Animal Health Products Market by Region, 2007 13
  226. Table 2.4: U.S. Animal Health Product Sales, 2005-2014 14
  227. Table 2.5: Animal Health Market: Sales Statistics-Europe, 2007 15
  228. Table 2.6: E.U. Animal Health Market, 2004-2014 16
  229. Table 2.7: Japanese Animal Health Market, 2000-2012 17
  230. Table 2.8: Chinese Animal Health Products Market, 2005-2012 19
  231. Table 2.9: Indian Animal Health Market, 2003-2010 20
  232. Table 2.10: Institutions Involved in Manufacturing Vaccines and Other Biological Products for Livestock 22
  233. Table 2.11: Worldwide Animal Health Product Sales for Leading Producers, 2007 23
  234. Table 2.12: Common Animal Diseases 25
  235. Table 2.13: Cattle Diseases 25
  236. Table 2.14: Sheep and Goat Diseases 26
  237. Table 2.15: Equine Diseases 26
  238. Table 2.16: Swine Diseases 26
  239. Table 2.17: Avian Diseases 27
  240. Table 2.18: Fish Diseases 27
  241. Table 2.19: Other Veterinary Diseases 27
  242. Table 2.20: Leading Companion-Animal Prescription Drugs by Sales, 2007 55
  243. Table 2.21: Worldwide Veterinary Vaccine Market, 2005-2012 57
  244. Table 2.22: U.S. Veterinary Vaccine Market, 2004-2013 58
  245. Table 2.23: Second-Generation Licensed/Commercialized Veterinary Viral Vaccines 59
  246. Table 2.24: Canine Vaccinations 61
  247. Table 2.25: Dog Vaccine Price List 61
  248. Table 2.26: American Association of Feline Practitioners 2006 Feline Vaccination Guidelines: Summary of Vaccination in General Practice. 62
  249. Table 2.27: Recently Commercialized Veterinary Bacterial Vaccines 67
  250. Table 2.28: Available Veterinary Live Protozoal Vaccines 68
  251. Table 2.29: Available Veterinary Killed/Subunit Protozoal Vaccines 68
  252. Table 2.30: Commercialized Reproduction Control Vaccines 68
  253. Table 2.31: Global Market for Nutraceutical in Companion Animals, 2005-2012 97
  254. Table 3.1: Veterinary Drugs Listed by Therapeutic Class 99
  255. Table 3.2: Sales of Pharmaceutical Products for Animal Health in the U.S., 2000-2008 104
  256. Table 3.3: Number of Dogs in the U.S., 1996-2008 105
  257. Table 3.4: Number of Pet Dogs by Geographical Region, 2008 105
  258. Table 3.5: Number of Cats in the U.S., 1996-2008 105
  259. Table 3.6: Number of Pet Cats by Geographical Region, 2008 105
  260. Table 3.7: U.S. Spending on Pet Care, 1996-2008 105
  261. Table 3.8: American Veterinary Specialists 106
  262. Table 3.9: Companion-Animal Products Sales, 2008 106
  263. Table 3.10: U.S. Antiparistic Animal Health Product Sales, 2005-2012 109
  264. Table 3.11: Global Antiparistic Animal Health Product Sales, 2005-2012 109
  265. Table 3.12: Worldwide Sales of Animal Health Antibiotics, 2005-2012 111
  266. Table 3.13: U.S. Volume of Animal Health Antibiotics Used, 2000-2006 111
  267. Table 3.14: U.S. Sales of Animal Health Antibiotics, 2005-2012 111
  268. Table 3.15: European Sales of Animal Health Antibiotics, 2005-2012 112
  269. Table 3.16: Common Veterinary Anti-Inflammatories 115
  270. Table 3.17: U.S. Pet Anti-Inflammatory Market, 2003-2012 115
  271. Table 3.18: Retail Pricing of Rimadyl 115
  272. Table 3.19: EtoGesic Pricing 116
  273. Table 3.20: Therapy for Various Pet Cancers 122
  274. Table 3.21: Mechanisms of Action, Indications and Toxicities of Selected Antineoplastic Agents 125
  275. Table 3.22: Treatment Options for Canine or Feline Lymphomas 127
  276. Table 3.23: Chemotherapeutic Agents Commonly Used in Veterinary Medicine, and the Associated Risks 129
  277. Table 3.24: Bacterial and Protozoal Threats to Poultry 133
  278. Table 3.25: Bacterial and Protozoal Threats to Pigs 133
  279. Table 3.26: Elanco Veterinary Products Summary 134
  280. Table 3.27: Wyeth Fort Dodge Animal Health Products 138
  281. Table 4.1: Global Sales of Feed Additives for Animal Health, 2005-2014 142
  282. Table 4.2: Target Species and Brand Names for Probiotics 146
  283. Table 4.3: Feed AdditivesAntimicrobials and Growth Promotants 148
  284. Table 4.4: Feed AdditivesAnthelmintics 148
  285. Table 4.5: U.S. Beef Exports, 2002-2007 148
  286. Table 4.6: Retail Equivalent Value of U.S. Beef Industry, 2002-2007 148
  287. Table 4.7: U.S. Revenues from Animal Agriculture by State, 2006 149
  288. Table 4.8: Use of Antibiotics as Growth Promotants 150
  289. Table 4.9: Global Market for Livestock Performance Enhancers, 2004-2010 151
  290. Table 5.1: Veterinary Diagnostics World Market, 2005-2012 156
  291. Table 5.2: Veterinary Immunodiagnostic Testing World Markets, 2005-2012 159
  292. Table 7.1: Labs that Perform Canine DNA Testing 197
  293. Table 7.2: DNA (Mutation) Tests for Canine Inherited Diseases 198
  294. Table 7.3: DNA (Marker) Tests for Canine Inherited Diseases 199
  295. Table 7.4: U.S. Companion Animal Prescription Drug Revenue, 2006 202
  296. Table 7.5: Companies Producing Generic Pharmaceuticals for Animal Health 203
  297. Table 7.6: Generics vs. Branded Animal Health Pharmaceuticals, 2005 204
  298. Table 7.7: U.S. Animal Health Generic Pharmaceuticals in the Pipeline, 2007 206
  299. Table 7.8: Veterinary Pet Insurance Rates and Coverage in the U.S., 2008 209
  300. Table 8.1: Pfizer Animal Health Products 250
  301. Table 8.2: Pfizer Products Patents 252
  302. Table 8.3: Key Pfizer Animal Health Products 254
  303. Table 8.4: Pfizer Livestock Products 254
  304. Table 8.5: Pfizer Equine Products 255
  305. Table 8.6: Pfizer Companion Animal Products 255
  306. Table 9.1: European Animal Health Market Sales, 2005-2012 266

Registration
Browse Reports
Search TriMark
Reading Room
My Account
View Cart
Home  |  Reports  |  Database Tables  |  Conferences  |  Contact Us  
     © 2008 TriMark Publications, LLC. All rights reserved.    Powered by Manta